ZNTL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Zentalis Pharmaceuticals (ZNTL) Earnings Date & Reports

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ZNTL is expected to report earnings to rise 48.07% to -82 cents per share on March 03

Zentalis Pharmaceuticals ZNTL Stock Earnings Reports

Q4'24

Est.

$-0.83

Q3'24

Beat

by $0.05

Q2'24

Missed

by $0.40

Q1'24

Beat

by $0.91

Q4'23

Est.

$-0.86

The last earnings report on November 06 showed earnings per share of -56 cents, beating the estimate of -60 cents. With 310.62K shares outstanding, the current market capitalization sits at 147.52M.

View a ticker or compare two or three

Compare

ZNTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ZNTL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1359 Broadway

Phone

+1 212 433-3791

Employees

168

Web

https://www.zentalis.com